NIH-funded research NIH-funded research

How cells fold proteins and handle misfolding

Official title: Protein folding in the cell: Challenges and coping mechanisms

Funded at University of Massachusetts Amherst · NIH-11376315 · Data updated 2026-11-12

This research looks at how cells use helper proteins called Hsp70 to fold other proteins properly and prevent the kind of misfolding that can lead to Alzheimer's.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Amherst
NIH-funded
Lab location1 site (Hadley, United States)
Project startJune 1, 2016
Project endMay 31, 2027
Funding year2025
Award (this year)$26,085
NIH project number3R35GM118161-10S1
Project IDNIH-11376315 on NIH RePORTER

Who could benefit from this research

Could help

This project is laboratory-focused and does not enroll patients, though people with Alzheimer's disease or related dementias could be future beneficiaries of therapies informed by these findings.

Less likely to help

People seeking immediate treatment or those whose cognitive problems are not driven by protein misfolding are unlikely to receive direct benefit from this laboratory research.

What this research studies

The research focuses on Hsp70 molecular chaperones, which switch between loose and tight binding states depending on ATP or ADP and help other proteins fold correctly. Scientists will use biochemical assays, structural analyses, and cell-based experiments to map which protein sequences Hsp70 binds and how partner co-chaperones (J-proteins and nucleotide-exchange factors) alter binding and release. The work is lab-based and examines molecular mechanisms rather than testing treatments in people. Findings aim to explain the molecular steps that can lead to harmful protein clumps in Alzheimer's and similar conditions.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or reduce protein misfolding and aggregation that contribute to Alzheimer's disease.

How similar studies have gone: Many laboratory and animal studies show Hsp70 chaperones can reduce protein aggregation, but translating these findings into proven human therapies remains largely unproven.

Where this research is happening

  • University of Massachusetts Amherst
    Hadley, United States
    Active

Researchers

  • Principal investigator: Gierasch, Lila M — University of Massachusetts Amherst
  • Study coordinator: Gierasch, Lila M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.